Ganstigmine: Completed Phase II study enrollment

Chiesi Farmaceutica S.p.A., Parma, Italy Product: Ganstigmine (CHF 2819) Business: Neurological Therapeutic category: Neuroprotectant Target: Cholinesterase Description: Selective inhibitor of acety...